MCID: MDD003
MIFTS: 35

Middle Cerebral Artery Infarction

Categories: Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Middle Cerebral Artery Infarction

MalaCards integrated aliases for Middle Cerebral Artery Infarction:

Name: Middle Cerebral Artery Infarction 38 12 14
Infarction, Middle Cerebral Artery 42 69
Infarction Middle Cerebral Artery 52

Classifications:



External Ids:

Disease Ontology 12 DOID:3525
MeSH 42 D020244
UMLS 69 C0740392

Summaries for Middle Cerebral Artery Infarction

MalaCards based summary : Middle Cerebral Artery Infarction, also known as infarction, middle cerebral artery, is related to myocardial infarction and cerebritis. An important gene associated with Middle Cerebral Artery Infarction is S100B (S100 Calcium Binding Protein B), and among its related pathways/superpathways is HIF-1 signaling pathway. The drugs Benzocaine and Nimodipine have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and bone marrow, and related phenotype is nervous system.

Related Diseases for Middle Cerebral Artery Infarction

Diseases related to Middle Cerebral Artery Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 62)
id Related Disease Score Top Affiliating Genes
1 myocardial infarction 27.9 CD40LG EDN1 PLAT S100B
2 cerebritis 10.9
3 meningitis and encephalitis 10.4 ENO2 S100B
4 benallegue lacete syndrome 10.4 ENO2 S100B
5 myoma 10.4 ENO2 S100B
6 enteric pattern testicular yolk sac tumor 10.4 ENO2 S100B
7 hydromyelia 10.4 ENO2 S100B
8 pituitary dwarfism with large sella turcica 10.4 ENO2 S100B
9 pediatric ependymoma 10.4 ENO2 S100B
10 mixed epithelial stromal tumour 10.4 ENO2 S100B
11 phobic disorder 10.4 ENO2 S100B
12 skin glomus tumor 10.4 ENO2 S100B
13 osteochondrodysplasia 10.4 ENO2 S100B
14 anal canal adenocarcinoma 10.4 ENO2 S100B
15 vulvar keratoacanthoma-like carcinoma 10.4 ENO2 S100B
16 ulcerative colitis 10.4 ENO2 S100B
17 cervical adenomyoma 10.3 ENO2 S100B
18 pulmonary immaturity 10.3 ENO2 S100B
19 brain meningioma 10.3 ENO2 S100B
20 sternum cancer 10.3 ENO2 S100B
21 dextrocardia with situs inversus 10.3 ENO2 S100B
22 hypoglossal nerve neoplasm 10.3 ENO2 S100B
23 kidney sarcoma 10.3 ENO2 S100B
24 connective tissue cancer 10.2 ENO2 S100B
25 inflammatory leiomyosarcoma 10.2 ENO2 S100B
26 spastic entropion 10.2 CD40LG ENO2
27 heart sarcoma 10.2 CD40LG S100B
28 adenosarcoma 10.2 ENO2 S100B
29 grade iii astrocytoma 10.1 ENO2 S100B
30 physical urticaria 10.1 CD40LG EDN1
31 brain edema 10.1
32 umbilical hernia 10.1 ENO2 S100B
33 periampullary adenoma 10.0 EDN1 S100B
34 gastrointestinal stromal tumor 10.0 ENO2 S100B
35 beach ear 9.9 CD40LG PLAT
36 progressive relapsing multiple sclerosis 9.9 CD40LG ENO2 S100B
37 prion disease with protracted course 9.9 ENO2 S100B
38 ischemia 9.9
39 glioblastoma 9.9
40 wallerian degeneration 9.9
41 hydrocephalus 9.9
42 malignant hypertension 9.9 CD40LG PLAT
43 mixed malaria 9.9 CD40LG PLAT
44 calcinosis 9.9 CD40LG EDN1
45 elizabethkingia anophelis infection 9.8 EDN1 PLAT
46 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 9.8 EDN1 ENO2 S100B
47 kala-azar 1 9.8 EDN1 ENO2 S100B
48 mixed germ cell-sex cord neoplasm 9.7 CD40LG PLAT
49 pure red-cell aplasia 9.7
50 transient cerebral ischemia 9.7

Graphical network of the top 20 diseases related to Middle Cerebral Artery Infarction:



Diseases related to Middle Cerebral Artery Infarction

Symptoms & Phenotypes for Middle Cerebral Artery Infarction

MGI Mouse Phenotypes related to Middle Cerebral Artery Infarction:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.02 CD40LG EDN1 ENO2 PLAT PLEKHM1

Drugs & Therapeutics for Middle Cerebral Artery Infarction

Drugs for Middle Cerebral Artery Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 76)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
2
Nimodipine Approved Phase 4 66085-59-4 4497
3
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
4
Cilostazol Approved Phase 4 73963-72-1 2754
5
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
6 Piracetam Approved Phase 4 7491-74-9
7
Abciximab Approved Phase 4 143653-53-6
8
Choline Approved, Nutraceutical Phase 4 62-49-7 305
9 tannic acid Approved, Nutraceutical Phase 4
10
Clopidogrel Approved, Nutraceutical Phase 4,Phase 3 120202-66-6, 113665-84-2 60606
11 Antihypertensive Agents Phase 4
12 calcium channel blockers Phase 4
13 Calcium, Dietary Phase 4,Phase 1,Phase 2
14 Cytidine Diphosphate Choline Phase 4
15 Nootropic Agents Phase 4
16 Vasodilator Agents Phase 4
17 Fibrinolytic Agents Phase 4,Phase 3,Phase 2
18 Tissue Plasminogen Activator Phase 4,Phase 3,Phase 2,Phase 1
19 Analgesics Phase 4,Phase 3,Phase 1,Phase 2
20 Analgesics, Non-Narcotic Phase 4,Phase 3
21 Anti-Asthmatic Agents Phase 4
22 Anti-Inflammatory Agents Phase 4,Phase 3
23 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3
24 Antipyretics Phase 4,Phase 3
25 Antirheumatic Agents Phase 4,Phase 3
26 Autonomic Agents Phase 4
27 Bronchodilator Agents Phase 4
28 Cyclooxygenase Inhibitors Phase 4,Phase 3
29 Neuroprotective Agents Phase 4
30 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2
31 Phosphodiesterase 3 Inhibitors Phase 4
32 Phosphodiesterase Inhibitors Phase 4
33 Platelet Aggregation Inhibitors Phase 4,Phase 3
34 Protective Agents Phase 4
35 Respiratory System Agents Phase 4
36 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
37 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2
38 Purinergic P2 Receptor Antagonists Phase 4,Phase 3
39 Purinergic P2Y Receptor Antagonists Phase 4,Phase 3
40 Pharmaceutical Solutions Phase 4,Phase 2
41 Plasminogen Phase 4,Phase 2,Phase 1
42 Antibodies Phase 4
43 Antibodies, Monoclonal Phase 4
44 Anticoagulants Phase 4
45 Immunoglobulin Fab Fragments Phase 4
46 Immunoglobulins Phase 4
47
Reteplase Approved Phase 3 133652-38-7 65820
48
Tenecteplase Approved Phase 3,Phase 2 191588-94-0
49
Mannitol Approved, Investigational Phase 3 69-65-8 453 6251
50
Xylometazoline Approved Phase 3 526-36-3 5709

Interventional clinical trials:

(show top 50) (show all 55)

id Name Status NCT ID Phase Drugs
1 Nimodipine for Treating Acute Massive Cerebral Infarction Unknown status NCT02248233 Phase 4 Nimodipine;Saline + citicoline
2 A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis Unknown status NCT01553643 Phase 4 Chinese Herb Huang-Chi-Wu-Wu-Tang;placebo
3 Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler Completed NCT00741286 Phase 4 Aspirin;cilostazol
4 Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II Completed NCT00130039 Phase 4 clopidogrel;Cilostazol
5 The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion Enrolling by invitation NCT02594995 Phase 4 NBP
6 A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke Terminated NCT01883011 Phase 4 Piracetam
7 Thrombectomy Under Reopro Versus Alteplase to Treat Stoke Terminated NCT02016547 Phase 4 alteplase 0.9mg/kg (10% by IV bolus following by 90% by 1 hour IV drip)
8 Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion Unknown status NCT00336596 Phase 3
9 Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke Completed NCT00604630 Phase 2, Phase 3 recombinant human erythropoietin alfa;0.9% NaCl
10 Endovascular Therapy for Acute Ischemic Stroke Trial Completed NCT02350283 Phase 3
11 Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting Recruiting NCT02351050 Phase 3
12 The Carotid and Middle Cerebral Artery Occlusion Surgery Study Recruiting NCT01758614 Phase 3 Aspirin;Clopidogrel
13 Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts Terminated NCT00190203 Phase 3
14 Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial Terminated NCT02002234 Phase 3
15 Carotid Occlusion Surgery Study Terminated NCT00029146 Phase 3 best medical therapy
16 Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct Unknown status NCT01461720 Phase 2
17 Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis Unknown status NCT01617538 Phase 1, Phase 2 atorvastatin
18 Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects Unknown status NCT01273337 Phase 2
19 Stem Cell Therapy For Acute Ischemic Stroke Patients Completed NCT02425670 Phase 2
20 Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients Completed NCT00950521 Phase 2 convention therapy
21 Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. Completed NCT00761982 Phase 1, Phase 2
22 Autologous Bone Marrow Stem Cells in Ischemic Stroke. Completed NCT00535197 Phase 1, Phase 2
23 Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase Completed NCT02259738 Phase 2 Human Urinary Kallidinogenase;Shuxuening injection
24 Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion Completed NCT00777140 Phase 2 Deferoxamine
25 Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke Recruiting NCT01468064 Phase 1, Phase 2
26 A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke Recruiting NCT02928393 Phase 2 Basmisanil;Placebo
27 Ketamine for Thrombolysis in Acute Ischemic Stroke Recruiting NCT02258204 Phase 1, Phase 2 Ketamine;Placebo
28 Pilot Investigation of Stem Cells in Stroke Phase II Efficacy Active, not recruiting NCT02117635 Phase 2
29 Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion Not yet recruiting NCT02338466 Phase 2 rt-PA;tenecteplase
30 The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018) Terminated NCT00401310 Phase 2 Comparator: Placebo;Comparator: MK0724
31 Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke Terminated NCT01310114 Phase 2 Placebo
32 Implantation of Olfactory Ensheathing Cells (OECs) Unknown status NCT01327768 Phase 1
33 Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke Unknown status NCT01438593 Phase 1
34 Intraarterial Stem Cells in Subacute Ischemic Stroke Completed NCT03080571 Phase 1
35 Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke Completed NCT00473057 Phase 1
36 Magnetic Resonance Imaging (MRI) Study of the Hippocampus After Infarction in the Territory of the Middle Cerebral Artery Unknown status NCT00867581
37 Stroke Imaging Package Study Unknown status NCT02485275
38 Use of Hypothermia During Robotic Prostatectomy Unknown status NCT00915031
39 Gait Training for Persons With Stroke Completed NCT00612300 Early Phase 1
40 Impact of Cranioplasty On Cerebral Perfusion Completed NCT01113645
41 ERic Acute StrokE Recanalization (ERASER) Completed NCT02534701
42 A Comparison Between Two Techniques for Performing Decompressive Craniectomy Completed NCT02594137
43 Effects of Carotid Stent Design on Cerebral Embolization Completed NCT00830232
44 Predictors of Early Chest Infection in Acute Ischemic Stroke Completed NCT00906542
45 Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery Recruiting NCT02609256
46 SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy Recruiting NCT02398734
47 Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke Recruiting NCT03086551
48 Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction Recruiting NCT02917213
49 Decompressive Hemicraniectomy in Intracerebral Hemorrhage Recruiting NCT02258919
50 Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH Recruiting NCT02907879

Search NIH Clinical Center for Middle Cerebral Artery Infarction

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Middle Cerebral Artery Infarction cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Middle Cerebral Artery Infarction:
Neuroncell
Embryonic/Adult Cultured Cells Related to Middle Cerebral Artery Infarction:
Bone marrow-derived mesenchymal stem cells (family)

Cochrane evidence based reviews: infarction, middle cerebral artery

Genetic Tests for Middle Cerebral Artery Infarction

Anatomical Context for Middle Cerebral Artery Infarction

MalaCards organs/tissues related to Middle Cerebral Artery Infarction:

39
Brain, Bone, Bone Marrow, Endothelial, Cortex, Pituitary, Thalamus

Publications for Middle Cerebral Artery Infarction

Articles related to Middle Cerebral Artery Infarction:

(show top 50) (show all 197)
id Title Authors Year
1
Protein microarray analysis identifies key cytokines associated with malignant middle cerebral artery infarction. ( 28828208 )
2017
2
National Survey of Neurosurgeons and Stroke Physicians on Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction. ( 28235642 )
2017
3
Decompressive hemicraniectomy for malignant middle cerebral artery infarction. Experience from the Western Province of Saudi Arabia. ( 28678213 )
2017
4
The Protective Effect of Middle Cerebral Artery Calcification on Symptomatic Middle Cerebral Artery Infarction. ( 28939676 )
2017
5
Predictors of early in-hospital death after decompressive craniectomy in swollen middle cerebral artery infarction. ( 27942881 )
2017
6
Malignant middle cerebral artery infarction. ( 28438757 )
2017
7
Clinical and Radiological Predictors of Malignant Middle Cerebral Artery Infarction Development and Outcomes. ( 28736129 )
2017
8
Massive Middle Cerebral Artery Infarction After Surgically Assisted Rapid Palatal Expansion: A Case Report. ( 28438597 )
2017
9
Decompressive craniectomy for the treatment of malignant middle cerebral artery infarction. ( 28604106 )
2017
10
Predictive factors for decompressive hemicraniectomy in malignant middle cerebral artery infarction. ( 26923797 )
2016
11
Malignant middle cerebral artery infarction: An unusual but severe neurovascular condition. ( 27147151 )
2016
12
Fluid Intake Related to Brain Edema in Acute Middle Cerebral Artery Infarction. ( 26666449 )
2016
13
10-Year Institutional Retrospective Case Series of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction (mMCAI). ( 27639522 )
2016
14
Reduction of Midline Shift Following Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction. ( 27733025 )
2016
15
Identification of cytokines for early prediction of malignant middle cerebral artery infarction. ( 26981614 )
2016
16
Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarction: The 'Real World' Beyond Studies. ( 27379413 )
2016
17
Timing of Symptomatic Infarct Swelling Following Intravenous Thrombolysis in Acute Middle Cerebral Artery Infarction: A Case-Control Study. ( 27443695 )
2016
18
Crossed cerebellar diaschisis in patients with acute middle cerebral artery infarction: Occurrence and perfusion characteristics. ( 26661242 )
2016
19
Functional Outcomes of Decompressive Craniectomy in Patients with Malignant Middle Cerebral Artery Infarction and Their Association with Preoperative Thalamus Deformation: An Analysis of 12 Patients. ( 27477404 )
2016
20
Analysis of the Outcome and Prognostic Factors of Decompressive Craniectomy between Young and Elderly Patients for Acute Middle Cerebral Artery Infarction. ( 27847759 )
2016
21
Decompressive craniectomy for malignant middle cerebral artery infarction in a 16-year old boy: a case report. ( 27998316 )
2016
22
Clinical course, prognostic factors, and long-term outcomes of malignant middle cerebral artery infarction patients in the modern era. ( 27147150 )
2016
23
Prediction of Malignant Middle Cerebral Artery Infarction in Elderly Patients. ( 27009609 )
2016
24
Association Between Prolonged Seizures and Malignant Middle Cerebral Artery Infarction in Children With Acute Ischemic Stroke. ( 27663488 )
2016
25
Predicting Mortality in Patients With "Malignant" Middle Cerebral Artery Infarction Using Susceptibility-Weighted Magnetic Resonance Imaging: Preliminary Findings. ( 26937906 )
2016
26
Impact of timing of cranioplasty on hydrocephalus after decompressive hemicraniectomy in malignant middle cerebral artery infarction. ( 28012353 )
2016
27
Decompressive craniectomy for severe middle cerebral artery infarction: a meta-analysis of randomised controlled trials. ( 27968912 )
2016
28
Neurologic Functional Outcomes of Decompressive Hemicraniectomy Versus Conventional Treatment for Malignant Middle Cerebral Artery Infarction: A Systematic Review and Meta-Analysis. ( 28024976 )
2016
29
Large Size Hemicraniectomy Reduces Early Herniation in Malignant Middle Cerebral Artery Infarction. ( 26855236 )
2016
30
De novo glioblastoma in the territory of a recent middle cerebral artery infarction and a residual meningioma: pathogenesis revisited. ( 27091344 )
2016
31
Decompressive craniectomy 116a88h after malignant middle cerebral artery infarction. ( 26892675 )
2016
32
Atypical Unilateral Posterior Reversible Encephalopathy Syndrome Mimicking a Middle Cerebral Artery Infarction. ( 26356795 )
2015
33
Effect of Intravenous Thrombolysis on the Time Course of the Apparent Diffusion Coefficient in Acute Middle Cerebral Artery Infarction. ( 25895155 )
2015
34
Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality. ( 25933254 )
2015
35
The prediction of malignant middle cerebral artery infarction: a predicting approach using random forest. ( 25804564 )
2015
36
Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: A systematic review and meta-analysis. ( 25661677 )
2015
37
Effect of Donepezil on Wernicke Aphasia After Bilateral Middle Cerebral Artery Infarction: Subtraction Analysis of Brain F-18 Fluorodeoxyglucose Positron Emission Tomographic Images. ( 26166237 )
2015
38
A Right Middle Cerebral Artery Infarct After Frontal Eosinophilic Granuloma Resection in an 8-Year-Old Boy with Factor V Leiden. ( 26442559 )
2015
39
Hemicraniectomy in older patients with malignant middle cerebral artery infarction. ( 25681285 )
2015
40
Predictors of malignant brain edema in middle cerebral artery infarction observed on CT angiography. ( 25510537 )
2015
41
Ethical considerations for craniectomy in malignant middle cerebral artery infarction: should we still deny our patient a life-saving procedure? ( 26404880 )
2015
42
Malignant middle cerebral artery infarction: a clinical study of 32 patients. ( 25857586 )
2015
43
Malignant Middle Cerebral Artery Infarction Resulting from Dissection of Middle Cerebral Artery. ( 26279098 )
2015
44
A Cohort Study of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Real-World Experience in Clinical Practice. ( 26107675 )
2015
45
Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction. ( 26030673 )
2015
46
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction. ( 26162891 )
2015
47
Improved hemodynamic parameters in middle cerebral artery infarction after decompressive craniectomy. ( 24736238 )
2014
48
Bilateral middle cerebral artery infarction associated with traumatic common carotid artery dissection: a case report and review of literature. ( 24480785 )
2014
49
Amusia for pitch caused by right middle cerebral artery infarct. ( 22877692 )
2014
50
A randomized clinical trial to assess the benefit of decompressive craniectomy in older patients with a large middle cerebral artery infarction. ( 25033363 )
2014

Variations for Middle Cerebral Artery Infarction

Expression for Middle Cerebral Artery Infarction

Search GEO for disease gene expression data for Middle Cerebral Artery Infarction.

Pathways for Middle Cerebral Artery Infarction

Pathways related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.62 EDN1 ENO2

GO Terms for Middle Cerebral Artery Infarction

Cellular components related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.02 CD40LG EDN1 ENO2 PLAT S100B

Biological processes related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cellular response to hypoxia GO:0071456 8.62 EDN1 S100B

Molecular functions related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 receptor binding GO:0005102 8.8 EDN1 PLAT S100B

Sources for Middle Cerebral Artery Infarction

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....